Notably, most breast tumors present alterations in different components of the PI3K pathway, with the most frequent being PTEN loss and activating mutations in PIK3CA, which encodes the catalytic subunit alpha of PI3K7,8. Here, PIK3CA is linked to breast neoplasm.